[Silymarin, a membranotropic drug: clinical and experimental observations].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001646:Bile / Q000378:metabolism; D002252:Carbon Tetrachloride Poisoning / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D006505:Hepatitis / Q000188:drug therapy; D006509:Hepatitis B / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000187:drug effects; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010590:Phalloidine / Q000506:poisoning; D011817:Rabbits; D012838:Silymarin / Q000494:pharmacology / Q000627:therapeutic use*
D005419:Flavonoids; D012838:Silymarin; D010590:Phalloidine
La silimarina, farmaco membranotropo: osservazioni cliniche e sperimentali.